Mohiuddin, Muhammad M.
Singh, Avneesh K.
Corcoran, Philip C.
Thomas III, Marvin L.
Clark, Tannia
Lewis, Billeta G.
Hoyt, Robert F.
Eckhaus, Michael
Pierson III, Richard N.
Belli, Aaron J.
Wolf, Eckhard
Klymiuk, Nikolai
Phelps, Carol
Reimann, Keith A.
Ayares, David
Horvath, Keith A.
Article History
Received: 20 January 2016
Accepted: 23 February 2016
First Online: 5 April 2016
Competing interests
: D.A. and C.P. are employees of Revivicor, Inc. K.A.R. owns equity in Primatope Therapeutics, which has licensed rights to the anti-CD40 antibody, 2C10.